Quantitative insights from breast cancer screening of 100,000 women in India using an artificial intelligence-based tool

Author:

Kakileti Siva Teja1,Manjunath Geetha1,Collison Sathiakar1,Madhu Himanshu J.1,Sampangi Sudhakar2,Prakash HV Ram3,Gupta Ashu4,Singh Sandeep4,Adapa Karthik4,Rajaneesh Nanda5,Wasker Anand6,Rastogi Sakshie7,San Anasuya8,Buggi Nirmala8,Palicheralu Balu S.9,Suresh HV10,Mehta Garima11,Lavingia Viraj12,Balai Ajay13,Y Naveen Bhat14,G.N Srinivasa14

Affiliation:

1. Niramai Health Analytix Pvt Ltd

2. Health Care Global Hospital

3. Central Diagnostic Research Foundation Bengaluru

4. Government of Punjab

5. Sakra World Hospital

6. Apollo Clinics

7. Healium Futuristics Private Limited

8. Bruhat Bengaluru Mahanagara Palike

9. Subbaiah Institute of Medical Sciences

10. Karnataka Cancer Society

11. Garima-can Foundation

12. Shalby Multi-Speciality Hospital

13. Universal Cancer Conquest

14. Govt. of Karnataka

Abstract

Abstract

Background Breast cancer is the leading cause of cancer-related deaths among women. Early detection is crucial for improving treatment outcomes and reducing costs. Systematic screening programs using mammography pose significant challenges in developing countries due to high-costs and skill shortages. Thermalytix is an affordable, portable, artificial intelligence (AI) based test that has demonstrated good clinical efficacy and economic feasibility for population-screening. This paper presents insights and data from implementing Thermalytix test on over 100,000 women in India. Methods Thermalytix was deployed at 150 clinical sites and at 1000 + screening camps outside hospitals. All women who took the test with informed consent, in either of these modes, were included to form a diverse cohort of 104,411 women from various socioeconomic backgrounds across 20 Indian-states. Thermalytix AI algorithms analyzed thermal patterns and automatically triaged women into three risk categories (red-yellow-green). Test Positivity Rate (TPR), assuming Red as test-positive, was computed for different cohorts. Results Thermalytix showed a TPR of 6.64% across the entire population. TPR in symptomatic women was 4x higher than in asymptomatic women. Women tested in hospitals exhibited a 1.6x higher TPR than those tested in screening camps. Highest TPR was observed in women aged above 60, followed by those aged 41–50 with complaints and those aged 31–40 without complaints. Postmenopausal women had a higher TPR than premenopausal women. Prior breast cancer led to a higher TPR than those without. Conclusion This study demonstrated the feasibility of implementing Thermalytix for community screening in resource-constrained countries, and the findings correlated with known risk-factors.

Publisher

Springer Science and Business Media LLC

Reference37 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3